eFFECTOR Therapeutics, Inc. (EFTR)
OTCMKTS: EFTR · Delayed Price · USD
0.0460
-0.0005 (-1.08%)
Jul 26, 2024, 3:52 PM EDT - Market closed
eFFECTOR Therapeutics Market Cap
eFFECTOR Therapeutics has a market cap or net worth of $216.40 thousand as of July 26, 2024. Its market cap has decreased by -99.45% in one year.
Market Cap
216.40K
Enterprise Value
-6.02M
1-Year Change
-99.45%
Ranking
n/a
Category
Stock Price
$0.05
Market Cap Chart
Since January 8, 2021, eFFECTOR Therapeutics's market cap has decreased from $175.80M to $216.40K, a decrease of -99.88%. That is a compound annual growth rate of -85.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 800.00K | -97.35% |
| Dec 29, 2023 | 30.20M | 68.72% |
| Dec 30, 2022 | 17.90M | -94.65% |
| Dec 31, 2021 | 334.30M | 90.16% |
| Jan 8, 2021 | 175.80M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 797.89B |
| Novo Nordisk | 582.53B |
| UnitedHealth Group | 522.51B |
| Johnson & Johnson | 383.91B |
| AbbVie | 322.57B |
| Merck & Co. | 321.97B |
| AstraZeneca | 239.44B |
| Thermo Fisher | 222.51B |